Welireg approved in US for rare VHL-associated cancers
VHL is a rare genetic disease which puts patients at risk of developing benign blood vessel tumours and several cancers
Read More
Tag: Welireg
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
